First order?Save 20%
(888) 510-7196
Caring SunshineIngredients

Columbine

Table of contents

Other Names

aguileñaAkeleiakeleieakelejeakileijaaklejaalpine columbineAmerican bluebellsAmerican columbineAmerican snapdragonamor-nascotoancolieAquilegiaAquilegia canadensisAquilegia vulgarisAquilinablodau'r sipsibreath of GodCanada columbineCanadian columbinecapon's tailcluckiescock's footcommon columbineculverwortdove planteastern columbineeastern red columbineEuropean columbineEuropean crowfootgants-de-Notre-Damegarden columbinegranny's bonnetgranny's bonnetshoneysucklejack-in-trousersl'ancolie communelady's shoeslion's herblus a' chalmainlusan a' chalmainmeetinghousesnaked woman's footnorthern bush-honeysucklepigeon flowerpigeon footRanunculaceae (family)red columbinerock bellsrock-lilyskógarvatnsberisow worttrue columbinewild columbinewild red columbinewild-honeysuckle

Synopsis

Columbine (Aquilegia spp.): A Comprehensive Encyclopedic Reference

1. Identity and Botanical Description

Botanical name: The genus Aquilegia L. (family Ranunculaceae) encompasses what is commonly known as columbine. The genus Aquilegia consists of approximately 70 species of perennial plants that have been used as both a medicinal substance and a food source throughout the northern hemisphere. The most extensively documented species in the European medicinal tradition is Aquilegia vulgaris L., while North American ethnobotany centers primarily on Aquilegia canadensis L. (eastern red columbine or wild columbine) and, to a lesser extent, Aquilegia formosa Fisch. ex DC. (western columbine). South and Central Asian traditions employ species including Aquilegia pubiflora Wall. ex Royle (Himalayan columbine) and Aquilegia fragrans Benth. (sweet-scented columbine).

Common names: Other common names for Aquilegia vulgaris include European columbine, true columbine, European crowfoot, culverwort, and granny's bonnet. The name Aquilegia comes from the Latin aquila (eagle), because the flower spurs look like an eagle's talons; the common name "columbine" comes from the Latin columba (dove), because when the flower is turned upside down, it looks like five doves huddled together.

Morphology and distribution: Aquilegia vulgaris is a species of perennial flowering plant in the family Ranunculaceae, commonly called common columbine, European crowfoot, and granny's bonnet; its current wild range includes its native range in Europe as well as introduced populations in Asia, Oceania, North America (where it has become naturalized), and South America. The wild form grows flowering stems that can reach 90 cm tall, and in its native range the species blooms from May to June. It is typically found at high altitudes in open meadows and woodlands, and is easy to identify due to the spurred petals of the flower, which look somewhat like a claw.

Plant parts used: The roots, leaves, flowers, and seeds have all been used in folk medicine. The flowers are edible, rich in nectar, sweet, and are also used as a tea substitute.

Taxonomy and species diversity: The genus Aquilegia belongs to the Ranunculaceae family, which has more than 60 species of plants that are used primarily in South Asia and worldwide for many medicinal purposes. Archaeological evidence suggests Aquilegia plants were in cultivation by the 3rd century AD in Roman Britain, and they remain popular in gardens worldwide.

Preparations and forms: Columbine has been prepared in several forms across different traditions, including decoctions and infusions of leaves and stems, root teas, seed powders, poultices from the root, tinctures, external lotions, and homeopathic preparations. A decoction from leaves and stems of Aquilegia vulgaris has been used in folk medicine against liver and bile duct disorders, especially for the treatment of jaundice and chronic skin inflammation. A homeopathic remedy is also made from the plant.

2. Traditional and Historical Use

2.1 Ancient and Classical Traditions

Columbines were associated with fertility goddesses in ancient Greek and ancient Roman religion, and were also connected to Christian religious concepts. The 1st-century AD Greek writer Dioscorides referred to columbine plants as Isopyrum, a name that is now applied to another genus. Columbine has been regarded as a religious symbol of purity and is often depicted in paintings together with the Virgin Mary.

2.2 Medieval European Tradition

It is known that the plant has been used as herbal medicine since the Middle Ages and that it was used as a remedy for many ailments, such as high fever due to infectious diseases, chronic rhinitis, haemoptysis (coughing up blood or blood-stained mucus from the bronchi), and enlarged or swollen lymph nodes in the neck. The plant was also used internally as a hepatic agent to treat jaundice and gallbladder ailments.

Hildegard of Bingen referred to the columbine as agleya. According to the Eclectic/Madaus historical herbal record, Hildegard applied columbine against swollen glands (geschwollene Drüsen). The 16th-century herbalist Matthiolus (Kreuterbuch, 1563) recognized Aquilegia as a medicinal plant and mentioned its use against jaundice, congested liver and spleen, and throat ailments; he also noted that chewing the root was thought to act prophylactically against kidney stone formation. Hildegard von Bingen used the aquilegia as a tincture to cure fever.

Columbine was formerly employed in herbal medicine mainly for its antiscorbutic effect, but it has fallen out of favour and is little used nowadays. Attributed traditional properties included antianxiety, astringent, depurative, diaphoretic, diuretic, and parasiticide actions, and it was also used in homeopathy.

Seventeenth-century herbalist Nicholas Culpeper wrote that "the leaves of columbine are successfully used in lotions for sore mouths and throat." Because columbine is slightly poisonous, its astringent properties are mainly exploited in lotions and used externally.

In Spain, there is a tradition of consuming small amounts of the columbine root in the morning for several days by those who are plagued by kidney stones.

2.3 Indigenous North American Traditions

Despite often being toxic, columbines have been in use by humans as herbal remedies, perfume, and food; Asian traditional medicine practitioners, Indigenous North Americans, and Medieval Europeans have considered portions of the plants to have medicinal uses.

The seeds of Aquilegia canadensis were crushed and used by American Indians for headaches, fevers, and as love charms; whole seeds were also rubbed into the scalp and hair to control lice. Additional ethnobotanical uses for the seeds include heart problems, skin rash or itch caused by poison ivy, kidney and urinary problems, and fever, as well as for ceremonial medicines, perfume, and as additives to tobacco. The roots, which are somewhat fleshy like carrots, were chewed or used to make a weak tea for diarrhea, stomach illness, and as a diuretic; a root tea was also used for uterine bleeding.

In Pawnee traditional medicine, it is a reputed cure for fever or headache if the seeds were crushed to powder in a mortar and pestle made of elm-wood and then made into a drink in hot water. In the traditional medicine of the Cherokee, a tea was made from Canadian columbine for "heart trouble."

Among the Iroquois, columbine (Aquilegia canadensis) was used as an infusion and wash to treat poison ivy.

Western tribes used a decoction of the roots for stomachaches or as a cough remedy, and the leaves were chewed for coughs or sore throat.

2.4 Asian Traditions

Himalayan Columbine (Aquilegia pubiflora Wall. Ex Royle) is a medicinal plant that has been used as a traditional treatment for various human diseases including skin burns, jaundice, hepatitis, wound healing, cardiovascular, and circulatory diseases.

Locally known as Domba and Thandi buti, Aquilegia pubiflora is reported to have many medicinal values including anti-asthmatic, astringent, stimulant, cardiotonic, febrifuge, jaundice, and dyspepsia properties; dried roots are used to treat toothache. Paste of dried flowers is used to treat boils and headache, while whole plants and seeds are used to cure pneumonia and jaundice.

3. Phytochemistry: Key Constituents and Active Compounds

Aquilegia species are rich in secondary metabolites, including alkaloids, flavonoids, cyanogenic glycosides, and volatile compounds, which contribute to their coloration, defense mechanisms, and pollinator attraction; over 57 natural compounds have been identified from 16 species since the 1960s, reflecting adaptations to diverse environments.

3.1 Alkaloids

Alkaloids are prominent in Aquilegia, with magnoflorine detected in all examined species and berberine present in eight out of ten; flavonoid alkaloids such as aquiledine and isoaquiledine are characteristic of the genus and have been isolated from Asian species like A. ecalcarata.

Magnoflorine is an aporphinoid quaternary alkaloid. Magnoflorine is a quaternary aporphine alkaloid that is widely distributed within the representatives of several botanical families; several findings mention its application in the treatment of a wide spectrum of diseases including inflammatory ones, allergies, hypertension, osteoporosis, bacterial, viral, and fungal infections, and some civilization diseases like cancer, obesity, diabetes, dementia, or depression.

Berberine is also present. Berberine is a naturally occurring alkaloid compound found in various medicinal plants belonging to Berberidaceae and Ranunculaceae families. Its distinctive chemical composition has been associated with a plethora of biological effects, including antioxidant, anti-inflammatory, antimicrobial, antidiabetic, anticancer, and cardiovascular properties, among others.

3.2 Flavonoids

Flavonoids comprise 38.5% of identified compounds in the genus, including flavonols and C-glycosides like vitexin, isovitexin, orientin, and isoorientin, quantified via HPLC. Several flavonoids and phenolic acids have been isolated and identified from the leaves, stems, and flowers, as well as alkaloids from roots.

In A. pubiflora, eight compounds, including four flavonoids (vitexin, orientin, isovitexin, and isoorientin) and four derivatives of hydroxycinnamic acid (chlorogenic acid, ferulic acid, sinapic acid, and p-coumaric acid), were identified and quantified for all leaf extracts.

In A. vulgaris, isocytisoside is a notable flavonoid: the content of isocytisoside in the ethyl-ether extract was quantified at 1.35%, and the content of phenolic acids (protocatechuic, p-coumaric, vanillic) was also determined.

3.3 Cyanogenic Glycosides

Aquilegia species with cyanophores (cells that produce a blue colour), including A. vulgaris, have been observed to contain the cyanogenic glycoside compounds dhurrin and triglochinin. Cyanogenic glycosides generally taste bitter and can be toxic to animals and humans.

3.4 Cycloartane-Type Triterpene Glycosides

Phytochemical studies of A. vulgaris have shown the presence of cyanogenic compounds, tannins, anthocyanins, and cycloartane derivatives showing immunosuppressive properties. Four new cycloartane glycosides, named aquilegiosides C–F, were isolated from the dried aerial parts of Aquilegia vulgaris, and their structures were determined by 2D NMR spectroscopic analysis and chemical evidence.

3.5 Other Compounds

Phytochemical studies across the genus have shown identification of flavonoids, alkaloids, cyanogenic constituents, cycloartane-type glycosides, butenolides, terpenoids, tannins, and unusual unsaturated fatty acids. Phytochemical studies of A. vulgaris specifically showed the presence of cyanogenic compounds, tannins, anthocyanins, and cycloartane derivatives showing immunosuppressive properties.

4. Established Mechanisms of Action

The pharmacological actions attributed to columbine preparations in laboratory studies are believed to derive from several classes of compounds acting through distinct mechanisms:

  • Antioxidant activity: The ethyl ether extract of A. vulgaris inhibited in vitro microsomal lipid peroxidation (IC50 58.8 µg/ml) and showed moderate ability to scavenge superoxide radicals and to chelate iron ions. Iron chelation and radical scavenging by phenolic compounds (including phenolic acids and flavonoids) are the proposed mechanisms.
  • Immunomodulation: Four new cycloartane glycosides, named aquilegiosides C–F, were isolated from dried aerial parts of Aquilegia vulgaris; their structures were determined by 2D NMR spectroscopic analysis, and aquilegiosides C–F suppressed the proliferation of lymphocytes in mouse allogeneic mixed lymphocyte reaction with IC(50) values ranging from 3.7×10⁻⁵ to 2.2×10⁻⁴ M.
  • Magnoflorine pharmacology: Findings in scientific literature mention magnoflorine's application in the treatment of a wide spectrum of diseases including inflammatory ones, allergies, hypertension, osteoporosis, bacterial, viral and fungal infections, and some civilization diseases like cancer, obesity, diabetes, dementia, or depression — although all such evidence for magnoflorine in columbine-specific studies is preclinical.
  • Berberine pharmacology: Berberine inhibits dipeptidyl peptidase-4 (DPP-4), an enzyme involved in the breakdown of incretin hormones, thus prolonging incretin hormone action and improving insulin secretion in diabetes management; it also inhibits the production of pro-inflammatory cytokines and reduces the activation of nuclear factor-kappa B pathways. These mechanisms are, however, established for berberine as an isolated compound in other species, not specifically from Aquilegia preparations.
  • Cytotoxic activity: In in vitro settings, Aquilegia pubiflora extracts were evaluated for cytotoxic activity; cytotoxic potential against the HepG2 cell line was assessed using doxorubicin as a positive control.

5. Scientific Evidence by Area of Use

It is essential to note that no clinical trials (human studies) have been published on columbine preparations as a therapeutic intervention. All experimental evidence derives from in vitro (cell-based) or animal studies, making the overall evidence base preliminary and weak. The following summarizes the best available preclinical data.

5.1 Antioxidant and Hepatoprotective Effects

Evidence type: Animal (rat) and in vitro studies.

An extract of A. vulgaris (100 mg/kg body weight, orally) decreased uninduced and enzymatic microsomal lipid peroxidation in the liver of male rats pretreated with carbon tetrachloride (CCl₄; 1 ml/kg body weight) by 27% and 40%, respectively. Several published studies have examined the protective effect of A. vulgaris extracts against acetaminophen (APAP)-induced oxidative stress in rats, against lead acetate-induced oxidative stress in rats, and against cadmium-induced mutagenic effects in Balb/c mice — all in preclinical animal models. No human data exist. The evidence is preliminary, restricted to animal and cell models, and does not establish efficacy in humans.

5.2 Immunomodulatory / Immunosuppressive Effects

Evidence type: In vitro (cell-based) study.

Aquilegiosides C–F, isolated from dried aerial parts of Aquilegia vulgaris, had their structures determined by 2D NMR spectroscopic analysis; aquilegiosides C–F suppressed the proliferation of lymphocytes in mouse allogeneic mixed lymphocyte reaction with IC(50) values ranging from 3.7×10⁻⁵ to 2.2×10⁻⁴ M. The herb is also a component of the immunostimulating preparation Padma 28 and homeopathic drugs. The apparent contradiction between immunosuppressive (isolated glycosides) and immunostimulating (Padma 28 preparation) designations reflects the complexity of polypharmacological plant action and the context-dependence of immune modulation. Evidence remains in vitro only; no controlled human data exist.

5.3 Antimicrobial Activity

Evidence type: In vitro studies.

Himalayan Columbine (Aquilegia pubiflora) has been used for decades to cure skin burns, jaundice, hepatitis, and wound healing; the purpose of a 2021 BMC study was to investigate phytochemical constituents and further evaluate the antimicrobial, anti-parasitic, anti-Alzheimer, and cytotoxic properties of Aquilegia pubiflora extracts. The evidence is in vitro only; clinical translation has not been demonstrated.

5.4 Cytotoxic / Anticancer Activity

Evidence type: In vitro (cell line) study.

Researchers have tested cytotoxic potential of A. pubiflora leaf extracts against the HepG2 (liver cancer) cell line in vitro. The cytotoxic potential was assessed against the HepG2 cell line; values represent mean ± SD of triplicates, with doxorubicin applied as a positive control. These are solely in vitro findings; no animal or human data on anticancer activity of columbine preparations exist in the peer-reviewed literature.

5.5 Erythroid Induction / Fetal Hemoglobin Induction

Evidence type: In vitro / preliminary research.

Research was conducted to screen the potential of A. fragrans and A. pubiflora as fetal hemoglobin inducers for β-thalassemia treatment, and to identify their secondary metabolites by chemical profiling using LC-ESI-QTOF tandem mass spectrometry. This represents an exploratory screening study; there are no clinical data on columbine as a treatment for β-thalassemia or any hemoglobinopathy.

5.6 Anti-Aging and Enzyme Inhibition

Evidence type: In vitro.

The 2021 BMC Complementary Medicine and Therapies study on A. pubiflora evaluated extracts for protein kinase inhibition (relevant to cancer pathways), acetylcholinesterase inhibition (relevant to Alzheimer's disease), and anti-inflammatory enzyme inhibition. Subsequently, all four types of leaf extracts were evaluated for their potential bioactivities including antimicrobial, protein kinase inhibition, and related activities. All findings are in vitro; no human trial data are available.

5.7 Summary of Evidence Strength

No randomized controlled trials, clinical trials, or systematic reviews have been published on columbine (Aquilegia spp.) as a medical or dietary supplement intervention. Columbine has produced very unsatisfactory results and is not normally used medicinally. The entire evidence base for pharmacological activity rests on in vitro cell assays and preclinical animal models. Individual bioactive constituents — notably magnoflorine and berberine — do have broader scientific literature, but this evidence pertains to isolated compounds from other botanical sources and cannot be extrapolated to columbine preparations without columbine-specific data.

6. Body Systems and Health Areas Associated with Columbine

Based on both traditional use claims and the available (preclinical) scientific evidence, Aquilegia species have been historically associated with the following body systems:

  • Hepatobiliary system: A decoction from leaves and stems of Aquilegia vulgaris has been used in folk medicine against liver and bile duct disorders, especially for the treatment of jaundice and chronic skin inflammation.
  • Cardiovascular system: According to toxicological plant listings, the entire plant of Aquilegia vulgaris affects the cardiovascular system through plant toxins. Paradoxically, the Cherokee used a tea from A. canadensis for "heart trouble," illustrating the dual nature of the plant — simultaneously a traditional cardiac remedy and a cardiac risk at higher doses.
  • Immune system: The plant's cycloartane glycosides display immunosuppressive activity in vitro, while the plant as a component in Padma 28 is labeled immunostimulating — reflecting the complexity of whole-plant preparations.
  • Skin and integument: External applications were used for ulcers, skin diseases, and poison ivy rash; the root is sometimes used externally in poultices to treat ulcers and the commoner skin diseases.
  • Digestive and urinary systems: The leaves, root, and seed are attributed astringent, depurative, diaphoretic, diuretic, and parasiticide properties.
  • Nervous system: The homeopathic remedy prepared from the plant is used in the treatment of affections of the nervous system.
  • Respiratory system: Traditional uses in South Asia include anti-asthmatic applications, and western tribes used root decoctions as a cough remedy.
  • Antiscorbutic (historical): In earlier European herbalism, columbine was valued for vitamin C-related nutritional support; however, columbine was formerly employed mainly for its antiscorbutic effect but has fallen out of favour.

7. Dosage Forms and Reported Dosages

There are no standardized, evidence-based dosages for columbine as a dietary supplement or herbal medicine. The following preparations and quantities appear in the literature solely in the context of historical, ethnobotanical, or preclinical research reports:

  • Animal study dosage (antioxidant): An ethyl ether extract of A. vulgaris was administered at 100 mg/kg body weight orally in male rats in experimental hepatoprotective studies.
  • In vitro HPLC-quantified extract: Four types of leaf extracts were prepared using solvents of different polarities (distilled water, methanol, ethanol, and ethyl acetate), and phytochemical constituents were quantified through HPLC analysis.
  • Traditional decoctions: Historical European folk practice described decoctions of leaves and stems used externally or in small doses internally for liver and skin complaints; no specific concentrations or quantities are documented in peer-reviewed literature.
  • Homeopathic preparation: A homeopathic remedy called Aqui is produced from the plant. Homeopathic preparations are typically used at highly diluted potencies; this is not equivalent to phytotherapeutic use.
  • Acute toxicity threshold (mice): An acute toxicity test in mice showed that ethanol extract and the main flavonoid compound isocytisoside from the leaves and stems of the species can be classified as nontoxic since a dose of 3000 mg/kg did not cause mortality in mice.

No standardized dosing guidance from any regulatory body (EMA, WHO, ESCOP, USP, Commission E) exists for columbine as a therapeutic preparation. Given documented toxicity at certain doses, any dose-finding must be considered very preliminary and investigational.

8. Safety Considerations and Toxicology

8.1 Acute Toxicity

Cyanogenic glycosides generally taste bitter and can be toxic to animals and humans; ingestion of 20 g of fresh A. vulgaris leaves by a human was observed as causing convulsions, respiratory distress, and heart failure. A child who consumed 12 A. vulgaris flowers experienced weakness of the limbs, cyanosis, drowsiness, and miosis; all symptoms abated after three hours.

8.2 Cardiogenic Toxins

There is considerable danger in ingesting seeds in large quantities, as they contain cardiogenic toxins that can affect the cardiovascular and gastrointestinal systems. The main toxic compounds found in columbine flowers and seeds are cardiogenic toxins, which can cause mild to moderate symptoms such as diarrhea, vomiting, and dehydration if ingested in large quantities; ingesting significant amounts of these toxins can also cause damage to the heart and nervous system, leading to more severe symptoms.

8.3 Cyanogenic Toxicity

Aquilegia contains magnoflorine and a hydrocyanic acid-forming glycoside. The toxins can be destroyed by drying or heating the plant parts.

8.4 Skin Irritation

The sap contains a compound called protoanemonin which can cause mild skin blistering or rashes in sensitive individuals. Protoanemonin is a reactive lactone characteristic of the Ranunculaceae family.

8.5 Toxicity Grading

The aquilegia does not pose any great danger to humans under typical exposure conditions; although symptoms of poisoning may occur, these also subside quickly. Since aquilegias are only slightly toxic to humans and larger animals such as dogs and cats, any symptoms usually subside quickly. However, this comparative mildness does not apply to large doses: because of its toxic properties, the plant should not be taken internally without expert advice, though the root is sometimes used externally in poultices.

8.6 Official Regulatory Standing

The Royal Botanic Gardens, Kew's Useful Plants and Fungi project has identified A. vulgaris as poisonous. There is no approved monograph for Aquilegia from the European Medicines Agency (EMA), the German Commission E, ESCOP, or any comparable authority. The absence of such approvals reflects both the limited clinical evidence base and documented safety concerns.

8.7 Pregnancy and Vulnerable Populations

No peer-reviewed clinical data on safety in pregnancy, lactation, pediatric populations, or in individuals with pre-existing cardiac disease are available. Historical use of root teas in traditional contexts (e.g., for uterine bleeding) does not constitute evidence of safety, and the documented cardiotoxic potential of seeds and roots warrants particular attention in these groups.

8.8 Drug Interactions

No formal pharmacokinetic drug-interaction studies have been published for columbine preparations. Given the presence of berberine — a compound known to inhibit cytochrome P450 enzymes (notably CYP3A4 and CYP2D6) in other plant species — theoretical interactions with medications metabolized by these enzymes are plausible, but no columbine-specific interaction data exist in the peer-reviewed literature.

References

Health Conditions

Health conditions that Columbine may help support.

  • No conditions available.

Body Systems

Body systems that Columbine may help support.

  • No body systems available.
Join our newsletter

Stay informed. Stay healthy.

Get expert supplement tips, exclusive discounts, and product recommendations delivered to your inbox

Columbine | Caring Sunshine